(Q84840694)
Statements
An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas (English)
M Agulnik
J L Yarber
S H Okuno
M von Mehren
B D Jovanovic
B E Brockstein
R S Benjamin
21 August 2012